A Clinical Experience on 30 Cases of Prostatic Carcinoma.
- Author:
Hee Chan LEE
1
;
Young Yo PARK
Author Information
1. Department of Urology, College of Medicine, Ewha Womans University, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
prostatic carcinoma
- MeSH:
Acid Phosphatase;
Alkaline Phosphatase;
Cause of Death;
Common Bile Duct;
Cystostomy;
Hematuria;
Humans;
Incidence;
Infarction;
Lung;
Lymph Nodes;
Male;
Neoplasm Metastasis;
Orchiectomy;
Palpation;
Prostate;
Prostatectomy;
Prostatism;
Testis;
Transurethral Resection of Prostate
- From:Korean Journal of Urology
1989;30(4):502-508
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Recently prostatic carcinoma has been considered as an important disease in urologic field, because its occurrence rate is increasing year by year. A clinical study was made on the 30 patients of prostatic carcinoma. The results were as follows: 1. The incidence was 11.4% of all male patients who had G-U tract tumors. The patients age ranged from 52 to 87 years (mean age 69.9 years). 2. The major symptoms were prostatism (70.0%), acute retention, hematuria and pain. 3. On the transrectal palpation of prostate, 23 patients (76.7%) had hard nodules. 4. The clinical stage were stage A 3,B 4, C 1 and : D22; and the grade I 4, II 16 and III 18, respectively. 5. Among 15 patients of bone metastasis, 6 patients (40.0%) had no pain, 6 patients (40.0%) had normal acid phosphatase level and 5 patients (33.3%) had normal alkaline phosphatase level. No one had bone pain, elevated acid or alkaline phosphatase level in 5 patients who had no bone metastatic lesion. 6. The site of metastasis in stage D patients (22 cases) was bone 14, lymph node 9, lung 2 and testicle 1 case. 7. For the relief of infravesical obstruction (17 cases), open prostatectomy, TURP and suprapubic cystostomy were performed in 3, 8 and 6 cases, respectively. For the treatment of stage D patients (22 cases), orchiectomy only, DES, DES +orchiectomy and irradiation were performed in 1, 5, 15 and 5 cases, respectively. 8. Among the 18 patients who could be followed, 11 patients had survived more than 3 years. Four patients were proved to be dead. The causes of death were metastasis, myocardiac infarction and common bile duct cancer.